See also: Mannkind: Analysts' Upgrades, DowngradesEditor's Note: Green and red arrows refer to intraday stock price movement. NEW YORK ( TheStreet) -- STOCK COMMENTS / EPS CHANGES Analog Devices ( ADI) numbers upped at UBS. ADI estimates were boosted through 2012, UBS said. Company is seeing healthy underlying demand. Neutral rating and new $40 price target. Adtran ( ADTN) estimates, target boosted at Goldman. Shares of ADTN now seen reaching $39. Estimates also upped, to match the company's new guidance. Neutral rating. Amphenol ( APH) estimates, target raised at UBS. Shares of APH now seen reaching $57, according to UBS. Estimates also increased, to match the company's new guidance. Neutral rating. eBay ( EBAY) price target higher at Credit Suisse to $34 from $32 after solid 4Q10 results. Healthy revenue growth at PayPal, augmented operating leverage, and progress at Marketplace, Credit Suisse said. Maintain Outperform rating. eBay ( EBAY) target, estimates boosted at Barclays. EBAY price target increased to $33 from $29. Strong 4Q10 earnings driven by improvements in payments margins, Barclays said. 2011 EPS estimate lifted to $1.95 from $1.85. Maintain Equal Weight rating. eBay ( EBAY) estimates, target boosted at UBS. Shares of EBAY now seen reaching $35. Estimates also upped, to match the company's new guidance. Buy rating. Esterline ( ESL) estimates, target increased at UBS through 2012, UBS said. Company's margins are improving. Neutral rating and new $72 price target. F5 Networks ( FFIV) numbers increased at Goldman. FFIV estimates were raised through 2013, Goldman Sachs said. Company is seeing better margins and taxes. Sell rating and new $90 price target. Goldman Sachs ( GS) estimate cut at Barclays. GS 2011 and 2012 EPS estimates lowered to $14.40 and $16.10, respectively. Weak earnings driven by slow December, Barclays said. Maintain Equal Weight rating and $175 price target. Goldman Sachs ( GS) target raised at FBR to $190. Company still delivered solid ROE, despite lower client activity. Outperform rating. Human Genome Sciences ( HGSI) numbers lowered at Piper. Shares of HGSI now seen reaching $33. Estimates also cut, as Benlysta might face a softer launch. Overweight rating. Linear Technology ( LLTC) numbers raised at UBS. Shares of LLTC now seen reaching $34, according to UBS. Estimates also increased, as bookings appear to be bottoming. Neutral rating.